Westchester Capital Management (New York)’s Frazier Lifesciences Acquisition Corporation Warrant FLACW Stock Holding History

Westchester Capital Management (New York)’s Portfolio FLACW Stock Details FLACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-24,559	Closed	-$18K	–	583
2022 Q3	$18K	Buy	+24,559	New	+$15.6K	﹤0.01%	433

Westchester Capital Management (New York)'s FLACW Position: Q4 2022 in Review

Westchester Capital Management (New York) sold out of Frazier Lifesciences Acquisition Corporation Warrant (FLACW) in Q4 2022, closing a stake of 24,559 shares — an estimated $18K sold.

Westchester Capital Management (New York) first reported a position in FLACW in Q3 2022 and held it in 1 quarter. The position peaked at $18K in Q3 2022. 0 funds tracked by Wall St. Rank hold FLACW as of Q4 2022.

Westchester Capital Management (New York) reported no remaining Frazier Lifesciences Acquisition Corporation Warrant position as of Q4 2022 after selling out during the quarter.
Westchester Capital Management (New York) sold 24,559 Frazier Lifesciences Acquisition Corporation Warrant shares in Q4 2022, an estimated $18K.
Westchester Capital Management (New York) first reported a position in Frazier Lifesciences Acquisition Corporation Warrant in Q3 2022 and held it in 1 quarter.
Westchester Capital Management (New York)'s Frazier Lifesciences Acquisition Corporation Warrant position peaked at $18K in Q3 2022.
0 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Warrant as of Q4 2022.

Based on Westchester Capital Management (New York)'s 13F filing for Q4 2022, filed 14 Feb 2023.